Dizziness / vertigo
This medicine may cause dizziness or vertigo.
Leaflet BIMATOPROST+TIMOLOL PHARMASWISS 0.3mg / 5mg / ml ophthalmic drops solution
- Product code:
- W64423001
- Quantity:
- 1
- Indicated for:
- glaucoma; ocular hypertension
- Route of administration:
- ophthalmic
- Substance:
- bimatoprost + timolol (glaucoma agent + beta blocker)
- ATC
- S01ED51 — Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
Precautions:
Hypotension / fall risk
May lower blood pressure and increase the risk of falls.
Elderly warning
Older people may have an increased risk of side effects.
The combination of bimatoprost and timolol is used to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Bimatoprost is a prostaglandin analog, and timolol is a beta-blocker; together, they work by increasing fluid outflow from the eye and reducing fluid production, thereby lowering pressure.
The medication is available as eye drops and is typically administered once daily in the evening. It is essential for patients to follow their doctor's instructions to prevent vision deterioration.
Common side effects include eye redness, burning sensation, itching, and dry eyes. In rare cases, systemic effects such as decreased heart rate or breathing difficulties may occur due to the presence of timolol.
This combination is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about any other conditions or medications being used to avoid drug interactions.
The medication is available as eye drops and is typically administered once daily in the evening. It is essential for patients to follow their doctor's instructions to prevent vision deterioration.
Common side effects include eye redness, burning sensation, itching, and dry eyes. In rare cases, systemic effects such as decreased heart rate or breathing difficulties may occur due to the presence of timolol.
This combination is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about any other conditions or medications being used to avoid drug interactions.
General data about BIMATOPROST+TIMOLOL PHARMASWISS 0.3mg / 5mg / ml
- Substance:
- bimatoprost + timolol
- Date of latest medicines list:
- 01-08-2018
- Product code:
- W64423001
- Concentration:
- 0.3mg / 5mg / ml
- Pharmaceutical form:
- ophthalmic drops solution
- Quantity:
- 1
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for bimatoprost + timolol
Concentrations available for bimatoprost + timolol
- 0.1mg/g+1mg/g
- 0.3mg/5mg/ml
- 300mcg/5mg/ml